EDGAR Filing Documents for 0001140361-23-035866

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001140361-23-035866

Filing Date

2023-07-24

Accepted

2023-07-24 16:40:44

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	ny20009756x1_s3.htm	S-3	337653
2	EXHIBIT 2.5	ny20009756x1_ex2-5.htm	EX-2.5	112119
3	EXHIBIT 5.1	ny20009756x1_ex5-1.htm	EX-5.1	10789
4	EXHIBIT 23.1	ny20009756x1_ex23-1.htm	EX-23.1	2191
5	EXHIBIT 23.2	ny20009756x1_ex23-2.htm	EX-23.2	2121
6	FILING FEES TABLE	ny20009756x1_ex107.htm	EX-FILING FEES	26940
7		logo_catalystbiox1.jpg	GRAPHIC	70509
8		logo_catalystbiox2.jpg	GRAPHIC	41712
9		ny20009756x1_ex5-1image01.jpg	GRAPHIC	2591
	Complete submission text file	0001140361-23-035866.txt		650805

Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080

Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761

CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-273395 | Film No.: 231105502
SIC: 2834 Pharmaceutical Preparations